Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium.

Authors:
Liangfeng Han Preethi Korangath Nguyen K Nguyen Adam Diehl Soonweng Cho Wei Wen Teo Leslie Cope Manfred Gessler Lewis Romer Saraswati Sukumar

Front Oncol 2020 15;10:581459. Epub 2021 Jan 15.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Blocking tumor angiogenesis is an appealing therapeutic strategy, but to date, success has been elusive. We previously identified HEYL, a downstream target of Notch signaling, as an overexpressed gene in both breast cancer cells and as a tumor endothelial marker, suggesting that HEYL overexpression in both compartments may contribute to neoangiogenesis. Carcinomas arising in double transgenic Her2-neu/HeyL mice showed higher tumor vessel density and significantly faster growth than tumors in parental Her2/neu mice. Providing mechanistic insight, microarray-based mRNA profiling of HS578T-tet-off-HEYL human breast cancer cells revealed upregulation of several angiogenic factors including CXCL1/2/3 upon HEYL expression, which was validated by RT-qPCR and protein array analysis. Upregulation of the cytokines CXCL1/2/3 occurred through direct binding of HEYL to their promoter sequences. We found that vessel growth and migration of human vascular endothelial cells (HUVECs) was promoted by conditioned medium from HS578T-tet-off-HEYL carcinoma cells, but was blocked by neutralizing antibodies against CXCL1/2/3. Supporting these findings, suppressing HEYL expression using shRNA in MDA-MB-231 cells significantly reduced tumor growth. In addition, suppressing the action of proangiogenic cytokines induced by HEYL using a small molecule inhibitor of the CXCl1/2/3 receptor, CXCR2, in combination with the anti-VEGF monoclonal antibody, bevacizumab, significantly reduced tumor growth of MDA-MB-231 xenografts. Thus, HEYL expression in tumor epithelium has a profound effect on the vascular microenvironment in promoting neoangiogenesis. Furthermore, we show that lack of HEYL expression in endothelial cells leads to defects in neoangiogenesis, both under normal physiological conditions and in cancer. Thus, HeyL-/- mice showed impaired vessel outgrowth in the neonatal retina, while the growth of mammary tumor cells E0771 was retarded in syngeneic HeyL-/- mice compared to wild type C57/Bl6 mice. Blocking HEYL's angiogenesis-promoting function in both tumor cells and tumor-associated endothelium may enhance efficacy of therapy targeting the tumor vasculature in breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.581459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845423PMC
January 2021

Publication Analysis

Top Keywords

heyl expression
16
breast cancer
12
tumor
10
heyl
9
cells
8
cancer cells
8
tumor epithelium
8
heyl-/- mice
8
endothelial cells
8
tumor cells
8
tumor growth
8
reduced tumor
8
mice
5
growth
5
protein array
4
profound vascular
4
validated rt-qpcr
4
vascular microenvironment
4
rt-qpcr protein
4
epithelium profound
4

Keyword Occurance

Similar Publications

Quinomycin A reduces cyst progression in polycystic kidney disease.

Authors:
Priyanka S Radadiya Mackenzie M Thornton Emily A Daniel Jessica Y Idowu Wei Wang Brenda Magenheimer Dharmalingam Subramaniam Pamela V Tran James P Calvet Darren P Wallace Madhulika Sharma

FASEB J 2021 May;35(5):e21533

Departments of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.

Polycystic kidney disease (PKD) is a genetic disorder characterized by aberrant renal epithelial cell proliferation and formation and progressive growth of numerous fluid-filled cysts within the kidneys. Previously, we showed that there is elevated Notch signaling compared to normal renal epithelial cells and that Notch signaling contributes to the proliferation of cystic cells. Quinomycin A, a bis-intercalator peptide, has previously been shown to target the Notch signaling pathway and inhibit tumor growth in cancer. Read More

View Article and Full-Text PDF
May 2021
Similar Publications

An experimental model of anti-PD-1 resistance exhibits activation of TGFß and Notch pathways and is sensitive to local mRNA immunotherapy.

Authors:
Marie Bernardo Tatiana Tolstykh Yu-An Zhang Dinesh S Bangari Hui Cao Kerstin A Heyl Joon Sang Lee Natalia V Malkova Katie Malley Eladio Marquez Jack Pollard Hui Qu Errin Roberts Sue Ryan Kuldeep Singh Fangxian Sun Emma Wang Keith Bahjat Dmitri Wiederschain Timothy R Wagenaar

Oncoimmunology 2021 Mar 16;10(1):1881268. Epub 2021 Mar 16.

Sanofi Research and Development, Cambridge, MA, USA.

Immune checkpoint blockade elicits durable anti-cancer responses in the clinic, however a large proportion of patients do not benefit from treatment. Several mechanisms of innate and acquired resistance to checkpoint blockade have been defined and include mutations of MHC I and IFNγ signaling pathways. However, such mutations occur in a low frequency of patients and additional mechanisms have yet to be elucidated. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium.

Authors:
Liangfeng Han Preethi Korangath Nguyen K Nguyen Adam Diehl Soonweng Cho Wei Wen Teo Leslie Cope Manfred Gessler Lewis Romer Saraswati Sukumar

Front Oncol 2020 15;10:581459. Epub 2021 Jan 15.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Blocking tumor angiogenesis is an appealing therapeutic strategy, but to date, success has been elusive. We previously identified HEYL, a downstream target of Notch signaling, as an overexpressed gene in both breast cancer cells and as a tumor endothelial marker, suggesting that HEYL overexpression in both compartments may contribute to neoangiogenesis. Carcinomas arising in double transgenic Her2-neu/HeyL mice showed higher tumor vessel density and significantly faster growth than tumors in parental Her2/neu mice. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Characterization of CHARK, an unusual cytokinin receptor of rice.

Authors:
Mhyeddeen Halawa Anne Cortleven Thomas Schmülling Alexander Heyl

Sci Rep 2021 Jan 18;11(1):1722. Epub 2021 Jan 18.

Institute of Biology/Applied Genetics, Dahlem Centre of Plant Science, Freie Universität Berlin, Albrecht-Thaer-Weg 6, 14195, Berlin, Germany.

The signal transduction of the plant hormone cytokinin is mediated by a His-to-Asp phosphorelay. The canonical cytokinin receptor consists of an extra cytoplasmic hormone binding domain named cyclase/histidine kinase associated sensory extracellular (CHASE) and cytoplasmic histidine kinase and receiver domains. In addition to classical cytokinin receptors, a different type receptor-named CHASE domain receptor serine/threonine kinase (CHARK)-is also present in rice. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Significant transcriptomic changes are associated with differentiation of bone marrow-derived mesenchymal stem cells into neural progenitor-like cells in the presence of bFGF and EGF.

Authors:
Amir Ali Khan Tee Jong Huat Abdullah Al Mutery Ahmed Taher El-Serafi Hassen Hadj Kacem Sallam Hasan Abdallah Muhammed Faruque Reza Jafri Malin Abdullah Hasnan Jaafar

Cell Biosci 2020 Oct 28;10(1):126. Epub 2020 Oct 28.

Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia Health Campus, Jalan Raja Perempuan Zainab II, 16150, Kubang Kerian, Kelantan, Malaysia.

Introduction: Mesenchymal stem cells (MSCs) isolated from bone marrow have different developmental origins, including neural crest. MSCs can differentiate into neural progenitor-like cells (NPCs) under the influence of bFGF and EGF. NPCs can terminally differentiate into neurons that express beta-III-tubulin and elicit action potential. Read More

View Article and Full-Text PDF
October 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap